NCT02197026View on ClinicalTrials.gov

Effectiveness and Safety of Synvisc® Versus Usual Treatments in Patients With Knee Osteoarthritis

PHASE4CompletedINTERVENTIONAL
Enrollment

518

Participants

Timeline

Start Date

October 31, 1998

Primary Completion Date

February 29, 2000

Conditions
Osteoarthritis
Interventions
DRUG

Hylan G-F 20

DRUG

Standard treatment

Standard drug treatment at the discretion of the investigator

PROCEDURE

Physiotherapy

PROCEDURE

Hydrotherapy

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY